Therapeutics Thursday (SCSS): HPV Vaccination: Changing Landscapes and New Challenges

Human Papillomavirus (HPV) is a common sexually transmitted infection and has been a public health target in the United States for some time. As many as 80%-90% of sexually active adults have contracted HPV and about 50% of infections are at high risk of leading to cancer. Despite the availability of commercial vaccinations for HPV, education of clinicians and patients alike remains less than optimal. Join us for a discussion on the current state of HPV vaccination in the United States and how pharmacists play a critical role. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.